The effect of a self-management program on the quality of life of patients with scleroderma

Razieh Parniyan,Nilofar Pasyar,Masoume Rambod,Marzieh Momennasab,Mohammadali Nazarinia
DOI: https://doi.org/10.4103/jehp.jehp_1690_22
2024-01-22
Abstract:Background: Scleroderma is a rare disease with complex disorders. It affects the quality of life with severe impacts on the skin and extensive complications in the internal organs, and does not have a definitive treatment. This study aimed to investigate the effect of a self-management program on the quality of life of patients with scleroderma. Materials and methods: This was a clinical trial in which 54 patients with scleroderma were randomly divided into two groups of 27 each (experimental and control groups). The data were collected using the Systemic Sclerosis Questionnaire. A self-management program was sent to the experimental group via a mobile phone application (WhatsApp) every day for three months. Statistical analysis was performed in Statistical Package for the Social Sciences V21. Results: The Wilcoxon signed-rank test showed that the average overall quality of life score of the experimental group showed a significant increase after the implementation of the program (P value: 0.00). The average overall quality of life score of the control group also significantly declined after the intervention (P value: 0.00). The Mann-Whitney U test revealed that there was no significant difference in the overall quality of life score of the two groups before the intervention (P value: 0.31); however, after the implementation of the self-management program, a significant difference was observed between the two groups (P value: 0.00). Conclusion: According to the results, the self-management program can help improve the quality of life of patients with scleroderma.
What problem does this paper attempt to address?